➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Colorcon
Baxter
Moodys
Merck

Last Updated: September 20, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ANASCORP

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for ANASCORP

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00624078 ↗ Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation Completed University of Arizona Phase 2/Phase 3 2005-05-01 This treatment protocol will enable therapeutic use of Anascorp in the management of systemic manifestations of scorpion sting envenomation, in patients for whom antivenom would otherwise be unavailable. The working hypotheses are as follows: 1. The investigational antivenom is safe as treatment of scorpion sting envenomation. 2. The investigational antivenom is effective as treatment of scorpion sting envenomation.
NCT00624078 ↗ Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation Completed Instituto Bioclon S.A. de C.V. Phase 2/Phase 3 2005-05-01 This treatment protocol will enable therapeutic use of Anascorp in the management of systemic manifestations of scorpion sting envenomation, in patients for whom antivenom would otherwise be unavailable. The working hypotheses are as follows: 1. The investigational antivenom is safe as treatment of scorpion sting envenomation. 2. The investigational antivenom is effective as treatment of scorpion sting envenomation.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ANASCORP

Condition Name

Condition Name for ANASCORP
Intervention Trials
Scorpion Sting Envenomation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ANASCORP
Intervention Trials
Poisoning 1
Bites and Stings 1
Scorpion Stings 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ANASCORP

Trials by Country

Trials by Country for ANASCORP
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ANASCORP
Location Trials
Arizona 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ANASCORP

Clinical Trial Phase

Clinical Trial Phase for ANASCORP
Clinical Trial Phase Trials
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ANASCORP
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ANASCORP

Sponsor Name

Sponsor Name for ANASCORP
Sponsor Trials
Instituto Bioclon S.A. de C.V. 1
University of Arizona 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ANASCORP
Sponsor Trials
Other 1
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Medtronic
Johnson and Johnson
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.